Quick Facts at a Glance
- Recall Date
- July 29, 2025
- Hazard Level
- HIGH
- Brands
- Levoxyl, Pfizer Laboratories Div Pfizer Inc
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- At-Risk Groups
- GENERAL, PREGNANT, ELDERLY
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Levoxyl, Pfizer Laboratories Div Pfizer Inc
- Product type
- Levothyroxine (Levoxyl) tablets
- Model numbers
- Lot #: 24C11, Exp 2/28/2026
- UPC codes
- 60793-850, 60793-851, 60793-852, 60793-853, 60793-854, 60793-855, 60793-856, 60793-857 +12 more
- Sizes
- 100-count bottle
- Sold at
- Multiple Retailers
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
July 29, 2025
Reported by FDA DRUG
August 20, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Subpotent drug
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Pfizer or your healthcare provider for guidance. Notification method: Letter
About This Product
Levoxyl is a brand of levothyroxine used to replace or supplement thyroid hormone. Patients depend on consistent dosing to manage hypothyroidism.
Why This Is Dangerous
Subpotent medication may not provide adequate thyroid hormone, reducing treatment efficacy and symptom control.
Industry Context
This recall is not part of a broader pattern of levothyroxine potency issues reported in recent months.
Real-World Impact
High if subpotent therapy leads to under-treatment of hypothyroidism; patients may need monitoring and dose adjustments.
Practical Guidance
How to identify if yours is affected
- Check NDC 60793-851-01 on your medication bottle.
- Look for Lot 24C11 and Exp 02/28/2026.
- Confirm 100-count Rx bottle and labeling 'Levoxyl'.
Where to find product info
On the bottle label, package insert, and Pfizer recall notices linked to FDA enforcement page.
What timeline to expect
Refunds or replacements depend on Pfizer notification and provider guidance; typically weeks to months.
If the manufacturer is unresponsive
- Document all communications with your pharmacy or prescriber.
- Escalate to Pfizer recalls hotline or FDA if no response.
How to prevent similar issues
- Verify potency if switching manufacturers or lots.
- Coordinate dose changes with a clinician during substitutions.
- Monitor thyroid levels when changing brands or lots.
Documentation advice
Keep bottle, packaging, receipt, and recall notices for records.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Brand: Levoxyl. Product: Levothyroxine sodium tablets, USP, 50 mcg. Bottle: 100-count. NDC: 60793-851-01. Distributed by Pfizer Inc., New York, NY 10017. Made in Austria. Lot: 24C11. Expiration: 02/28/2026. Quantity: 29,004 bottles. Sold as Rx-only. Distribution: Within the U.S.
Reported Incidents
No injuries or incidents have been reported in the recall notice.
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
